Loading...
MiR-450a-5p strengthens the drug sensitivity of gefitinib in glioma chemotherapy via regulating autophagy by targeting EGFR
Glioma reported to be refractory to EGFR tyrosine kinase inhibitor is the most common malignant tumor in central nervous system. Our research showed the low expression of miR-450a-5p and high expression of EGFR in glioma tissues. MiR-450a-5p was also observed to synergize with gefitinib to inhibit t...
Saved in:
| Published in: | Oncogene |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Nature Publishing Group UK
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7515841/ https://ncbi.nlm.nih.gov/pubmed/32820249 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-020-01422-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|